India’s Strategic Response: Transforming Pharmaceutical Tariff Pressure into Global Leadership
President Trump's 100% tariff on branded pharmaceutical imports, effective October 1, 2025, has created immediate market turbulence for Indian pharmaceutical stocks while revealing deeper strategic opportunities for the world's largest…